These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8440266)

  • 21. Improved tumour localisation using indium-111 labelled antibodies.
    Fairweather DS; Bradwell AR; Dykes PW; Vaughan AT; Watson-James SF; Chandler S
    Br Med J (Clin Res Ed); 1983 Jul; 287(6386):167-70. PubMed ID: 6409238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.
    Kairemo KJ; Ramsay HA; Tagesson M; Jekunen AP; Paavonen TK; Jääskelä-Saari HA; Liewendahl K; Ljunggren K; Savolainen S; Strand SE
    Eur J Nucl Med; 1996 Jun; 23(6):631-8. PubMed ID: 8662096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scintigraphic determination of the biodistribution of an 111In-labelled poly(L-lysine) backbone branched polypeptide drug carrier in tumour-bearing mice.
    Pimm MV; Perkins AC; Gribben SJ; Hudecz F
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):104-8. PubMed ID: 7632752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles.
    Proffitt RT; Williams LE; Presant CA; Tin GW; Uliana JA; Gamble RC; Baldeschwieler JD
    Science; 1983 Apr; 220(4596):502-5. PubMed ID: 6836294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour scanning with indium-111 dihaematoporphyrin ether.
    Quastel MR; Richter AM; Levy JG
    Br J Cancer; 1990 Dec; 62(6):885-90. PubMed ID: 2147858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of pulmonary uptake of indium-111 labelled granulocytes in inflammatory bowel disease.
    Ussov WY; Peters AM; Hodgson HJ; Hughes JM
    Eur J Nucl Med; 1994 Jan; 21(1):6-11. PubMed ID: 8088288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodistribution, radiation dosimetry and pharmacokinetics of 111In-antimyosin in idiopathic inflammatory myopathies.
    Smith T; Senior R; Raval U; Dasgupta B; Lahiri A
    J Nucl Med; 1999 Mar; 40(3):464-70. PubMed ID: 10086712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice.
    Proffitt RT; Williams LE; Presant CA; Tin GW; Uliana JA; Gamble RC; Baldeschwieler JD
    J Nucl Med; 1983 Jan; 24(1):45-51. PubMed ID: 6848703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
    Krenning EP; Bakker WH; Kooij PP; Breeman WA; Oei HY; de Jong M; Reubi JC; Visser TJ; Bruns C; Kwekkeboom DJ
    J Nucl Med; 1992 May; 33(5):652-8. PubMed ID: 1349039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging and assessment of regional clearances of indium-111 labelled circulating immune complexes in humans.
    Wirquin E; Bruneau C; Meignan M; Cinotti L; Sobel A
    Eur J Nucl Med; 1986; 12(5-6):274-6. PubMed ID: 3780771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.
    Li S; Peck-Radosavljevic M; Kienast O; Preitfellner J; Havlik E; Schima W; Traub-Weidinger T; Graf S; Beheshti M; Schmid M; Angelberger P; Dudczak R
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):198-206. PubMed ID: 15499293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs.
    Berry CR; Fisher P; Koblik PD; Guilford WG; Hornof WH
    Am J Vet Res; 1997 Nov; 58(11):1188-92. PubMed ID: 9361875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Planar gamma camera quantitation of 123I, 99mTc or 111In in the liver and spleen of an abdominal phantom.
    Macey DJ; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 1999 Aug; 14(4):299-306. PubMed ID: 10850316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour imaging with labelled liposomes.
    Briele B; Hotze A; Oehr P; Biersack HJ; Rosanowski F; Gorgulla W; Hertberhold C; Harlapp JP
    Lancet; 1990 Oct; 336(8719):875-6. PubMed ID: 1976895
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging.
    Ogawa M; Umeda IO; Kosugi M; Kawai A; Hamaya Y; Takashima M; Yin H; Kudoh T; Seno M; Magata Y
    J Nucl Med; 2014 Jan; 55(1):115-20. PubMed ID: 24337605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
    Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
    J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide.
    Förster GJ; Engelbach MJ; Brockmann JJ; Reber HJ; Buchholz HG; Mäcke HR; Rösch FR; Herzog HR; Bartenstein PR
    Eur J Nucl Med; 2001 Dec; 28(12):1743-50. PubMed ID: 11734910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
    Stillebroer AB; Zegers CM; Boerman OC; Oosterwijk E; Mulders PF; O'Donoghue JA; Visser EP; Oyen WJ
    J Nucl Med; 2012 Jan; 53(1):82-9. PubMed ID: 22159179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.